|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/6883 | (2018.01) |
| C12Q 1/6883 | (2013.01) | ||
| C12Q2600/156 | (2013.01) |
| (11) | Number of the document | 3969620 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20730885.9 |
| Date of filing the European patent application | 2020-05-16 | |
| (97) | Date of publication of the European application | 2022-03-23 |
| (45) | Date of publication and mention of the grant of the patent | 2025-06-25 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2020/033315 |
| Date | 2020-05-16 |
| (87) | Number | WO 2020/236670 |
| Date | 2020-11-26 |
| (30) | Number | Date | Country code |
| 201962849670 P | 2019-05-17 | US | |
| 201962933181 P | 2019-11-08 | US |
| (72) |
DAMASK, Amy , US
PAULDING, Charles , US
BARAS, Aris , US
ABECASIS, Goncalo , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707,
US
|
| (54) | GENOME-BASED METHODS FOR REDUCING CARDIOVASCULAR RISK |
| GENOME-BASED METHODS FOR REDUCING CARDIOVASCULAR RISK |